Development and evaluation of biodegradable chitosan microspheres loaded with ranitidine and cross linked with glutar aldehyde

American Journal of Drug Discovery and Development

Volumn 1, Issue 2, 2011, Pages 105-120

  Ramachandran, S ^a   Thirumurugan, G ^a   Dhanaraju, M D ^a  

^a GIET School of Pharmacy   (India)

Author keywords

Chitosan; Controlled release; Duodenal antiulcer activity; Glutar aldehyde saturated toluene (GST); In vivo gastric activity; Ranitidine

Indexed keywords

CHITOSAN; GLUTARALDEHYDE; MICROSPHERE; RANITIDINE; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIULCER ACTIVITY; ARTICLE; BIODEGRADABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSS LINKING; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DUODENUM ULCER; EMULSION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; NONHUMAN; PARTICLE SIZE; PH; RAT; STOMACH ULCER; THERMAL ANALYSIS;

EID: 79957581102     PISSN: 2150427X     EISSN: 21504296     Source Type: Journal    
DOI: 10.3923/ajdd.2011.105.120     Document Type: Article

References (50)

1. Aboofazeli, R. and A. Shafaati, 2002. Comparative bioavailability of Ranitidine Tablets in healthy volunteers. Iran. J. Pharm. Res., 1: 1-6.
2. Agnihotri, S.A. and T.M. Aminabhavi, 2004. Controlled release of clozapine through chitosan microparticles prepared by a novel method. J. Control Release., 96: 245-259.
3. Alkaysi, H.N, M.A.S. Salem, A.M. Gharaibeh and Y.M. El-Sayed, 1989. Bioeqmvalency of Ranitidine tablets. J. Clin. Pharm. Therap, 14: 111-117.
4. Anoop, A. and M. Jegadeesan, 2003. Biochemical studies on the anti-ulcerogenic potential of Hemidesmus indicus R.Br. var. indicus. J. Ethnopharmacol., 84: 149-156.
5. Berthold, A., K. Cremer and J. Kreuter, 1996. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J. Control Release, 39: 17-25.
6. Bhave, A.L., J.D. Bhatt and K.G. Hemavathy, 2006. Anti ulcer effect of amlodipine and its interaction with H2 blocker and proton pump inhibitor in pylorus ligated rats. Indian J. Pharmacol., 38: 403-407.
7. Blanco, M.D., C. Gomez, R. Olmo, E. Muniz and J.M. Teijon, 2000. Chitosan microspheres in PLG films as devices for cytarabine release. Int. J. Pharma., 202: 29-39.
8. Blanco, M.D., M.V. Bernardo, R.L. Sastre, R. Olmo, E. Muniz and J.M. Teijon, 2003. Preparation of bupivacaine-loaded poly (e-caprolactone) microspheres by spray drying: Drug release studies and bio compatibility. Eur. J. Pharma. Biopharma., 55: 229-236.
9. Bruntan, L.L., J.S. Lazo and K.L. Parker, 2006. Goodman and Gilman's, The Pharmacological Basis of Therapeutics. 11th Edn., McGraw-Hill Companies, New York.
10. Cervera, M.F., J. Heinamaki, K. Krogars and A.C. Jorgenson, 2004. Solid state and mechanical properties of aqueous chitosan-Amylose starch films plasticized with polyols. AAPS Pharm. Sci. Tech, 5: 15-15.
11. Chen, J.P. and J.Y. Chen, 1998. Preparation and characterization of immobilized phospholipase-A2 on chitosan beads for lowering serum cholesterol concentration. J. Mol. Catal. B: Enzym, 5: 483-490.
12. Cheng, Y.H, A.M. Margaret, I. Jabbal-Gill, M. Hmchehffe, R. Nankervis, A. Smith and P. Watts, 2005. Intranasal delivery of recombinant human growth hormone (somatotropin) in sheep using chitosan based powder formulations. Eur. J. Pharm. Sci, 26: 9-15.
13. Coffin, M.D. and Parr A.F, 1995. Ranitidine solid dosage form. US Patent, 5: 407-487.
14. Corrigan, D.O, A.M. Healy and O.I. Corrigan, 2006. Preparation and release of salbutamol from chitosan and chitosan co-spray dryed compacts and multi particulates. Eur. J. Pharma. Biopharma, 62: 295-305.
15. Dhanikula, A.B. and R. Panchagnula, 2004. Development and characterization of biodegradable chitosan films for local delivery of paclitaxel. AAPS Pharm. Sci. Tech, 6: 88-99.
16. Gladiziwa, U. and U. Klotz, 1993. Pharmacokinetics and Pharmacodynamics of H2 receptor antagonists in patients with renal insufficiency. Clin. Pharmacokinetics, 24: 319-332.
17. Goel, R.K. and S.K. Bhattacharya, 1991. Gastro duodenal mucosal defense and mucosal protective agents. Indian. J. Exp. Biol, 29: 701-714.
18. Goel, R.K. and B.S. Shah, 2008. Elements of Pharmacology. 17th Edn, Prakashan Publishers, India, pp: 440-443.
19. Grenha, A, B. Seijo and C. Remunan-Lopez, 2005. Microencapusulated chitosan nanoparticles for lung protein delivery. Eur. J. Pharm. Sci, 25: 427-437.
20. Guerrero, S, C. Teijon, E. Muniz, J.M. Teijon and M.D. Blanco, 2010. Characterization and in vivo evaluation of ketotifen-loaded chitosan microspheres. Carbohydrate Polymers, 79: 1006-1013.
21. Hillyard, I.W, J. Doczi and Kiernan, 1964. Antacid and antiulcer properties of the polysaccharide chitosan in the rat. Proc. Soc. Exp. Biol. Med, 115: 1108-1112.
22. Huang, Y.C, C.H. Chiang and M.K. Yeh, 2003. Optimizing formulation factors in preparing chitosan mi crop articles by spray-drying method. J. Microencapsulation, 20: 247-260.
23. Jaimini, M., A.C. Rana and Y.S. Tanwar, 2007. Formulation and evaluation of famotidine floating tablets. Curr. Drug. Deliv., 4: 51-55.
24. Jameela, S.R. and A. Jayakrishnan, 1995. Glutaraldehyde cross linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: Studies on the in vitro release of mitoxanthrone and in vivo degradation of microspheres in rat muscle. Biomaterials, 16: 769-775.
25. Jiang, D.S., S.Y. Long, J. Huang, H.Y. Xiao and J.Y. Zhou, 1998. Immobilisation of pycnoporus sanguineus laccase on magnetic chitosan microspheres. Biochem. Eng. J., 25: 15-23.
26. Kath, R.K. and R.K. Gupta, 2006. Antioxidant activity of hydroalcoholic leaf extract of ocimum sanctum in animal models of peptic ulcer. Indian J. Physiol. Pharmacol., 50: 391-396.
27. Kofuji, K., C.J. Qian, Y. Murata and S. Kawashima, 2005. Preparation of chitosan mi crop articles by water in vegetable oil emulsion clalescence technique. React. Func. Polym., 62: 77-83.
28. Kulkarni, S.K., 1985. Handbook of Experimental Pharmacology. 3rd Edn., Vallabh Prakashan, New Delhi.
29. Kumar, M.N.V.R., 2001. A review of chitin and chitosan applications. React. Funct. Polym., 46: 1-27.
30. Kunchandy, J., S. Khanna and S.K. Kulkarni, 1985. Effect of alpha 2 agonists clonidine, guanfacine and B-HT 920 on gastric acid secretion and ulcers in rats. Arch. Int. Pharmacodyn Ther, 275: 123-138.
31. Liao, S.K. and C.C. Hung, 2004. A kinetic study of thermal degradation of chitosan/polycaprolactam blends. Macromol. Res., 12: 466-473.
32. Manonmani, S., V.P. Viswanathan, S. Subramanian and S. Govindasamy, 1995. Biochemical studies on the antiulcerogenic activity of cauvery 100, an ayurvedic formulation in experimental ulcers. Indian J. Pharmacol., 27: 101-105.
33. Murata, Y., Y. Kontani, H. Ohmae and S. Kawashima, 2002. Behavior of alginate gel beads containing chitosan salt prepared with water-soluble vitamins. Eur. J. Pharm. Biopharm., 53:249-251.
34. Orienti, I., K. Aiedeh, E. Gianasi, V. Bertasi and V. Zecchi, 1996. Indomethacin loaded chitosan microspheres, correlation between the erosion process and release kinetics. J. Microencapsul, 13: 463-472.
35. Ouchi, T., T. Banba, M. Fujimoto and S. Hamamoto, 1989. Synthesis and antitumor activity of chitosan carrying 5-fluorouracils. Makromol. Chem., 190: 1817-1825.
36. Paolicelli, P., M. de la Fuente, A. Sanchez, B. Seijo and M.J. Alonso, 2009. Chitosan nanoparticles for drug delivery to the eye. Expert Opin. Drug Deliv., 6: 239-253.
37. Patel, J.K. and M.M. Patel, 2007. Stomach specific anti-helico bacter pylori theraphy: Preparation and evaluation of Amoxicillin-loaded chitosan muco adhesive microspheres. Currt. Drug Deliv., 4:41-50.
38. Qurashi, M.T., H.S. Blair and S.J. Allen, 1992. Studies on modified chitosan membranes. Studies on modified chitosan membranes. I Preparation and characterization. J. Applied Poly. Sci, 46:255-261.
39. Remuman-Lopez, C, M.L. Loremzo-Lamosa, Z.L. Vila-Jato and M.J. Alonso, 1998. Development of new chitosan-celllose multi core microparticle for controlled drug delivery. Eur. J. Pharm. Biopharm., 45: 49-56.
40. Reynolds, J.E.F., 1996. Martindale the Extra Pharmacopoeia. The Royal Pharmaceutical Society, London, PP: 18-20.
41. Sharma, V.N, 2007. Essentials o f Pharmacology. 3rd Edn., CBS Publishers, New Delhi.
42. Shi, X.Y. and T.W. Tan, 2002. Preparation of chitosan/ethyl cellulosecomplex microcapsule and its application in controlled release of vitamin D. Biomaterials, 23: 4469-4473.
43. Smith, I.L., J.A. Ziemniak, H. Benrhard, F.N. Eshelman, L.E. Martin and J.J. Schentag, 1984. Ranitidine disposition and systemic availability in hepatic cirrhosis. Ciln. Pharmacol. Therp., 35: 487-494.
44. Tamizharasi, S., J.C. Rathi and V. Rathi, 2008. Formulation and evaluation of pentoxifylline-loaded polycaprolactone microspheres. Indian J. Pharm. Sci., 70: 333-337.
45. Thanoo, B.C., M.C. Sunny and A. Jayakrishnan, 1992. Cross-linked chitosan microspheres: Preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J. Pharm. Pharmacol., 44: 283-286.
46. Thanoo, B.C., M.C. Sunny and A. Jayakrishnan, 1993. Oral sustained release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluid. J. Pharm. Pharmacol, 45:21-24.
47. Trapani, G, A. Lopedota, G. Boghetich, A. Latrofa, M. Franco and E. Sanna, 2003. Encapsulation and release of the hypnotic agent Zolpidem from biodegradable polymer micro particles containing hydroxypropyl-b-cyclodextrin. Int. J. Pharma, 268: 47-57.
48. Upadrashta, S.M, P.R. Katikaneni and N.O. Nuessle, 1992. Chitosan as a tablet binder. Drug Dev. Ind. Pharm, 18: 1701-1708.
49. Wilfried, F. and K. Karin, 1997. Crystalline cyclodextrin complexes of ranitidine hydrochloride, process for their preparation and pharmaceutical compositions containing the same. US Patent 5665767. http://www.everypatent.com/comp/pat5665767.html.
50. Wittaya-Areekul, S, J. Kruenate and C. Prahsarn, 2006. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan mi crop articles containing prednisolone. Int. J. Pharma, 312: 113-118.